About the journal
Official Journal of the Society of Radiopharmaceutical Sciences
Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science for imaging as well as therapeutic applications. More specifically the synthesis (automated and manual), in vitro and ex …
$3370
Article publishing charge
for open access
16 days
Time to first decision
77 days
Review time
95 days
Submission to acceptance
Editor-in-Chief
View full editorial boardArticles
Short communicationAbstract onlyMay–June 2024
https://doi.org/10.1016/j.nucmedbio.2024.108895
Research articleAbstract onlyMay–June 2024
https://doi.org/10.1016/j.nucmedbio.2024.108906
Research articleFull text accessMarch–April 2024View PDF
https://doi.org/10.1016/j.nucmedbio.2024.108893
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.nucmedbio.2024.108894
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.nucmedbio.2024.108892
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.nucmedbio.2024.108879
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.nucmedbio.2024.108890
More from Nuclear Medicine and Biology
Calls for papers
Practical aspects, status, and future perspectives of application of alpha-emitting radionuclides for targeted alpha therapy
Guest editors: Valery Radchenko, Cathy Cutler, Andrew Burgoyne, Amir Jalilian - Submission deadline: 1 September 2024
Targeted Alpha Therapy (TAT) holds great promise as the most efficient treatment option for late-stage metastatic cancers at the clinical level. Despite rapid progress with the clinical translation of several alpha emitters into clinical trials, …
The Future of the Radiopharmaceutical Sciences
Guest editors: Peter Scott, Suzanne Lapi - Submission deadline: 31 October 2023
A special issue of Nuclear Medicine and Biology (NMB), published by Elsevier, will be dedicated to the Future of the Radiopharmaceutical Sciences.
Special issues and article collections
Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2023
November–December 2023
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy
Edited by Salvatore Bongarzone, Zhengxin (Jason) Cai, Fabien Caillé, Melissa Deri, Fany Pricile Ekoume, Antonio Shegani, Valery Radchenko
12 September 2022
Print ISSN: 0969-8051
Online ISSN: 1872-9614
Copyright © 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies